Advanced search
Start date
Betweenand

Adjuvant effect of Propionibacterium acnes and its soluble polysaccharide fraction on immunogenicity of vaccine against HIV-1

Grant number: 14/25307-4
Support type:Regular Research Grants
Duration: August 01, 2015 - July 31, 2018
Field of knowledge:Biological Sciences - Immunology
Principal Investigator:Ieda Maria Longo Maugéri
Grantee:Ieda Maria Longo Maugéri
Home Institution: Escola Paulista de Medicina (EPM). Universidade Federal de São Paulo (UNIFESP). Campus São Paulo. São Paulo , SP, Brazil
Assoc. researchers:Daniela Santoro Rosa ; Edecio Cunha Neto

Abstract

The epidemic caused by the human immunodeficiency virus (HIV-1) is the most important emerging infection in the last decades. Despite that, there is no effective vaccine against this virus yet. It is expected that prevention should be achieved by the action of neutralizing antibodies, mainly directed against the virus envelope glycoprotein (gp140), while reduction of virus replication and control of viremia should be given by CD4+ and CD8+ T cells specific responses.Considering the important role of CD4+ T lymphocytes, recently a DNA vaccine encoding 18 HIV-1 epitopes directed to these cells has been developed and showed to induce strong, broad, polyfunctional and long-lasting HIV-specific CD4+ CD8+ T cells responses in BALB/c mice and also in mice transgenic to multiple common HLA class II molecules.Adjuvants are known for enhancing vaccines immunogenicity and are fundamental components on a vaccination strategy. The bacterium Propionibacterium acnes and its soluble polysaccharide fraction (PS) have been extensively evaluated by their adjuvant effects on cellular and humoral immune response, increasing phagocytic activities of macrophages, pathogen resistance and antigen specific antibodies synthesis. Both P. acnes and PS showed to be able to modulate Th1/Th2 polarization, by acting directly on antigen-presenting cells, modifying patterns of co-stimulatory molecules and toll-like receptors expression, leading to the production of different types of cytokines.Given the challenge of transferring the success of inducing potent immunity of DNA vaccines observed in animal models to humans, and also given the important role of CD4+ T cells in promoting humoral response, the aim of these study is to verify whether P. acnes and PS could improve immunogenicity of DNA vaccine HIVBr18 and whether an initial immunization with this vaccine could increase the magnitude and quality of humoral and cellular immune response induced by gp140. (AU)

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
SILVEIRA, GABRIELA DA PAZ; ISHIMURA, MAYARI EIKA; TEIXEIRA, DANIELA; GALINDO, LAYLA TESLA; SARDINHA, AGNES ARAUJO; PORCIONATTO, MARIMELIA; LONGO-MAUGERI, IEDA MARIA. Improvement of Mesenchymal Stem Cell Immunomodulatory Properties by Heat-Killed Propionibacterium acnes via TLR2. FRONTIERS IN MOLECULAR NEUROSCIENCE, v. 11, JAN 10 2019. Web of Science Citations: 0.
TEIXEIRA, DANIELA; ISHIMURA, MAYARI EIKA; APOSTOLICO, JULIANA DE SOUZA; VIEL, JACQUELINE MIYUKI; PASSARELLI, VICTOR CABELHO; CUNHA-NETO, EDECIO; ROSA, DANIELA SANTORO; LONGO-MAUGERI, IEDA MARIA. Propionibacterium acnes Enhances the Immunogenicity of HIVBr18 Human Immunodeficiency Virus-1 Vaccine. FRONTIERS IN IMMUNOLOGY, v. 9, FEB 7 2018. Web of Science Citations: 2.

Please report errors in scientific publications list by writing to: cdi@fapesp.br.